Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
Published September 18, 2019 · Recall initiated: August 30, 2019
Summary
FDA records drug Class II recall D-1849-2019, published September 18, 2019 and initiated August 30, 2019. Recalling firm: Pacifico National, Inc. dba AmEx Pharmacy; Status: Terminated; Lot: All lots remaining within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pacifico National, Inc. dba AmEx Pharmacy
- Distributor
- Continental U.S. and Puerto Rico
- Lot
- All lots remaining within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAGatifloxacin Ophthalmic Solution 0.5%, 2.5 mL per bottle, Rx Only, Mfd. for: Mylan Pharmaceuticals Inc.,September 18, 2019
- FDAPramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA,September 18, 2019
- FDALamivudine Tablets, USP, 150 mg, 30 (3x10) count Unit Dose Blisters Carton, NDC 60687-362-21 (Individual DoseSeptember 18, 2019
- FDABacteriostatic Water for Injection, USP, 30 mL vials, Rx only, Mfd. for: Hospira, Inc., Lake Forest, IL 60045September 18, 2019
- FDAOMNIlife science, Inc. ApeX acetabular liner hip prosthesis component Serf Dual Mobility Cup Insert LinerSeptember 11, 2019
- FDAAvastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St SuiteJune 1, 2016
Questions about this recall
Was Bevacizumab, 2.5 mg/0.1 mL, Norm-Ject Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 recalled?
Yes. FDA published recall D-1849-2019 on September 18, 2019. Reported hazard: Lack of assurance of sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release